Brighton Implant Clinic Ltd - Accounts to registrar (filleted) - small 18.2

Brighton Implant Clinic Ltd - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v19.3.2.199 06844311 director 1.4.18 31.3.19 31.3.19 false true false false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure068443112018-03-31068443112019-03-31068443112018-04-012019-03-31068443112017-03-31068443112017-04-012018-03-31068443112018-03-3106844311ns14:PoundSterling2018-04-012019-03-3106844311ns10:Director12018-04-012019-03-3106844311ns10:PrivateLimitedCompanyLtd2018-04-012019-03-3106844311ns10:SmallEntities2018-04-012019-03-3106844311ns10:AuditExempt-NoAccountantsReport2018-04-012019-03-3106844311ns10:SmallCompaniesRegimeForDirectorsReport2018-04-012019-03-3106844311ns10:SmallCompaniesRegimeForAccounts2018-04-012019-03-3106844311ns10:FullAccounts2018-04-012019-03-310684431112018-04-012019-03-3106844311ns10:OrdinaryShareClass12018-04-012019-03-3106844311ns10:RegisteredOffice2018-04-012019-03-3106844311ns5:CurrentFinancialInstruments2019-03-3106844311ns5:CurrentFinancialInstruments2018-03-3106844311ns5:Non-currentFinancialInstruments2019-03-3106844311ns5:Non-currentFinancialInstruments2018-03-3106844311ns5:ShareCapital2019-03-3106844311ns5:ShareCapital2018-03-3106844311ns5:RetainedEarningsAccumulatedLosses2019-03-3106844311ns5:RetainedEarningsAccumulatedLosses2018-03-3106844311ns5:IntangibleAssetsOtherThanGoodwill2018-04-012019-03-3106844311ns5:ComputerSoftware2018-04-012019-03-3106844311ns5:LeaseholdImprovements2018-04-012019-03-3106844311ns5:PlantMachinery2018-04-012019-03-3106844311ns5:MotorVehicles2018-04-012019-03-3106844311ns5:ComputerSoftware2018-03-3106844311ns5:ComputerSoftware2019-03-3106844311ns5:ComputerSoftware2018-03-3106844311ns5:LeaseholdImprovements2018-03-3106844311ns5:PlantMachinery2018-03-3106844311ns5:MotorVehicles2018-03-3106844311ns5:LeaseholdImprovements2019-03-3106844311ns5:PlantMachinery2019-03-3106844311ns5:MotorVehicles2019-03-3106844311ns5:LeaseholdImprovements2018-03-3106844311ns5:PlantMachinery2018-03-3106844311ns5:MotorVehicles2018-03-3106844311ns5:CurrentFinancialInstrumentsns5:WithinOneYear2019-03-3106844311ns5:CurrentFinancialInstrumentsns5:WithinOneYear2018-03-3106844311ns5:BetweenTwoFiveYearsns5:Non-currentFinancialInstruments2019-03-3106844311ns5:BetweenTwoFiveYearsns5:Non-currentFinancialInstruments2018-03-3106844311ns10:OrdinaryShareClass12019-03-31


REGISTERED NUMBER: 06844311















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2019

FOR

BRIGHTON IMPLANT CLINIC LTD

BRIGHTON IMPLANT CLINIC LTD (REGISTERED NUMBER: 06844311)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2019




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


BRIGHTON IMPLANT CLINIC LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2019







DIRECTOR: B M Silva





REGISTERED OFFICE: 12 Church Road
Hove
East Sussex
BN3 2FL





REGISTERED NUMBER: 06844311





ACCOUNTANTS: Cardens Accountants LLP
The Old Casino
28 Fourth Avenue
Hove
East Sussex
BN3 2PJ

BRIGHTON IMPLANT CLINIC LTD (REGISTERED NUMBER: 06844311)

BALANCE SHEET
31 MARCH 2019

2019 2018
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 3 1,480,000 1,850,000
Tangible assets 4 882,137 902,634
2,362,137 2,752,634

CURRENT ASSETS
Stocks 5 40,000 40,000
Debtors 6 185,083 245,157
Cash at bank and in hand 113,219 60,675
338,302 345,832
CREDITORS
Amounts falling due within one year 7 747,182 623,445
NET CURRENT LIABILITIES (408,880 ) (277,613 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,953,257

2,475,021

CREDITORS
Amounts falling due after more than one
year

8

1,392,371

1,951,290
NET ASSETS 560,886 523,731

CAPITAL AND RESERVES
Called up share capital 9 2 2
Retained earnings 560,884 523,729
SHAREHOLDERS' FUNDS 560,886 523,731

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2019.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2019 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the
end of each financial year and of its profit or loss for each financial year in accordance with the requirements of
Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to
financial statements, so far as applicable to the company.

BRIGHTON IMPLANT CLINIC LTD (REGISTERED NUMBER: 06844311)

BALANCE SHEET - continued
31 MARCH 2019


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director on 18 December 2019 and were signed by:





B M Silva - Director


BRIGHTON IMPLANT CLINIC LTD (REGISTERED NUMBER: 06844311)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2019

1. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

This is the first year in which the financial statements have been prepared under FRS 102. Any changes in
accounting policy have been applied from the first day of the previous period. Equity has been reconciled to
the previously stated amounts for the opening and closing position of the comparative period.

Turnover

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost
less any accumulated amortisation and any accumulated impairment losses.

Computer software is being amortised evenly over its estimated useful life of ten years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Improvements to property - 7% on cost
Plant and machinery - 25% on reducing balance
Motor vehicles - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and
slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except
to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or
substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the
balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different
from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and
laws that have been enacted or substantively enacted by the year end and that are expected to apply to the
reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that
they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the
lease.

2. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 55 (2018 - 63 ) .

BRIGHTON IMPLANT CLINIC LTD (REGISTERED NUMBER: 06844311)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2019

3. INTANGIBLE FIXED ASSETS
Computer
software
£   
COST
At 1 April 2018
and 31 March 2019 3,700,000
AMORTISATION
At 1 April 2018 1,850,000
Amortisation for year 370,000
At 31 March 2019 2,220,000
NET BOOK VALUE
At 31 March 2019 1,480,000
At 31 March 2018 1,850,000

4. TANGIBLE FIXED ASSETS
Improvements
to Plant and Motor
property machinery vehicles Totals
£    £    £    £   
COST
At 1 April 2018 967,244 674,927 10,970 1,653,141
Additions - 130,665 - 130,665
Disposals - - (1,440 ) (1,440 )
At 31 March 2019 967,244 805,592 9,530 1,782,366
DEPRECIATION
At 1 April 2018 314,745 429,420 6,342 750,507
Charge for year 64,483 85,066 1,006 150,555
Eliminated on disposal - - (833 ) (833 )
At 31 March 2019 379,228 514,486 6,515 900,229
NET BOOK VALUE
At 31 March 2019 588,016 291,106 3,015 882,137
At 31 March 2018 652,499 245,507 4,628 902,634

5. STOCKS
2019 2018
£    £   
Stocks 40,000 40,000

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2019 2018
£    £   
Trade debtors 67,361 124,082
Other debtors 13,051 3,752
Prepayments and accrued income 104,671 117,323
185,083 245,157

BRIGHTON IMPLANT CLINIC LTD (REGISTERED NUMBER: 06844311)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2019

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2019 2018
£    £   
Bank loans and overdrafts 213,174 89,525
Trade creditors 390,987 427,559
Social security and other taxes 12,121 24,218
Other creditors 101,302 67,294
Accrued expenses 29,598 14,849
747,182 623,445

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2019 2018
£    £   
Bank loans - 2-5 years 448,710 481,301
Directors' loan accounts 943,661 1,469,989
1,392,371 1,951,290

9. CALLED UP SHARE CAPITAL


Allotted, issued and fully paid:
Number: Class: Nominal 2019 2018
value: £    £   
2 Ordinary £1 2 2

10. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

During the year, B Silva. decreased his loan to the company. As at 31 March 2019, the company owed him
£943,661. (2018: £1,469,989.).
This balance represented the maximum amount outstanding during the year and the loan is interest free and
repayable on demand.

11. ULTIMATE CONTROLLING PARTY

The company's ultimate controlling parties are Mr B M Silva and Mrs M A J Silva by virtue of their combined
100% shareholding in the company.